E-086

Supelco

3-epi-25-Hydroxyvitamin D3 solution

50 μg/mL in ethanol, certified reference material, Cerilliant®

Empirical Formula (Hill Notation):
C27H44O2
CAS Number:
Molecular Weight:
400.64
MDL number:
PubChem Substance ID:
NACRES:
NA.24

Quality Level

grade

certified reference material

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

50 μg/mL in ethanol

mp

-144.0 °C

format

single component solution

storage temp.

−20°C
−70°C

SMILES string

C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@H](O)CCC3=C

InChI

1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23-,24-,25+,27-/m1/s1

InChI key

JWUBBDSIWDLEOM-UEGFJKGBSA-N

Looking for similar products? Visit Product Comparison Guide

General description

A Certified Spiking Solution® of 3-epi-25-Hydroxyvitamin D3, the epi isomer of the prohormone 25-hydroxyvitamin D3. The presence of 3-epi-25-hydroxyvitamin D3 can affect accurate quantitation of 25-hydroxyvitamin D3 levels by most routine LC-MS/MS methods and to an unknown extent in immuno- and protein binding assays. This solution standard is suitable for critical quantitative applications in research and clinical environments including: for use in preparation of controls and calibrators for LC/UV and LC-MS/MS assays; as system tuning/suitability standards; linearity verification; internal proficiency testing; and for OEM use in preparation of reagents, development of assays and instrument IQ/OQ.

Application

3-epi-25-Hydroxyvitamin D3 may be used as a certified reference material (CRM) for the determination of the analyte in biological fluids by different chromatography techniques.

Legal Information

CERILLIANT is a registered trademark of Cerilliant Corporation
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation

Pictograms

FlameExclamation mark

Signal Word

Danger

Hazard Statements

RIDADR

UN1170 - class 3 - PG 2 - Ethanol

WGK Germany

WGK 1

Flash Point(F)

57.2 °F - closed cup

Flash Point(C)

14.0 °C - closed cup

Certificate of Analysis
Certificate of Origin
Measurement of serum 3-epi-25-hydroxyvitamin D3, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in infant, paediatric and adolescent populations of Korea using ultra-performance liquid chromatography-tandem mass spectrometry
Cho SE, et al.
Annals of Clinical Biochemistry, 54(5), 530-538 (2017)
A Method for Simultaneous Determination of 25-Hydroxyvitamin D3 and Its 3-Sulfate in Newborn Plasma by LC/ESI-MS/MS after Derivatization with a Proton-Affinitive Cookson-Type Reagent
Higashi T, et al.
Mass Spectrom., 5(2), S0051-S0051 (2016)
Determination of four sulfated vitamin D compounds in human biological fluids by liquid chromatography--tandem mass spectrometry
Gomes FP, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 1009(5), 80-86 (2016)
Articles
This application shows an Ascentis Express F5 provided rapid resolution of the isobaric vitamin D metabolites. MS detection provides the necessary secondary resolution.
Read More
Related Content
The metabolic role and health implications of the various vitamin D isoforms are of current clinical interest. Therefore, it is important to have an analytical method that will resolve all of the known isoforms with necessary sensitivity and specificity
Read More

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.